Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-207876
Filing Date
2013-05-08
Accepted
2013-05-08 17:24:18
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d515467d10q.htm 10-Q 604889
2 EX-10.1 d515467dex101.htm EX-10.1 448668
3 EX-10.2 d515467dex102.htm EX-10.2 88720
4 EX-31.1 d515467dex311.htm EX-31.1 6033
5 EX-31.2 d515467dex312.htm EX-31.2 6017
6 EX-32.1 d515467dex321.htm EX-32.1 4679
  Complete submission text file 0001193125-13-207876.txt   3954895

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acrx-20130331.xml EX-101.INS 470685
8 XBRL TAXONOMY EXTENSION SCHEMA acrx-20130331.xsd EX-101.SCH 32737
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20130331_cal.xml EX-101.CAL 41797
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20130331_def.xml EX-101.DEF 173719
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20130331_lab.xml EX-101.LAB 250948
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20130331_pre.xml EX-101.PRE 203447
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 13825660
SIC: 2834 Pharmaceutical Preparations